ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Why Novo Nordisk Stock Slumped on Monday
Key PointsAn analyst downgraded his recommendation on the Danish pharmaceutical's equity.
Announcement as on 29 September 2025

Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditions
Novo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, including Wegovy, to treat conditions like knee osteoarthritis and sleep apnea. Clinical trials are planned to investigate the impact of C
Announcement as on 16 September 2025

Novo Nordisk Wins EU Label Update For Rybelsus To Include Heart Benefits
(RTTNews) - Novo Nordisk B A/S (NVO), Monday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has approved a label update for Rybelsus to include cardiovascular benefits demonstrated in the SOUL trial.
Announcement as on 15 September 2025

European shares rise as Inditex leads retailers, Novo Nordisk shines
European shares experienced a rise, propelled by strong performances in the retail sector, particularly Inditex, which reported accelerated sales. Novo Nordisk also saw gains following its restructuring announcement, including workforce reductions, aimed a
Announcement as on 10 September 2025

Novo Nordisk ties up with Apollo Clinics for obesity management initiative
Novo Nordisk partners with Apollo Clinics to tackle obesity in India. The collaboration introduces a comprehensive obesity management programme across Indian cities. This initiative aims to provide structured care through multiple levels. The partnership f
Announcement as on 01 September 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 41.75
  • 12Day Average: 40.74
  • 20Day Average: 39.66
  • 50Day Average: 38.86
  • 100Day Average: 46.13
  • 150Day Average: 48.06
  • 200Day Average: 50.32

NVO Indicators & signals

Indicator MACD (12,26,9)

40.84, 40.01, 0.33
Indicator MACD is in positive zone

Indicator ADX (14)

27.47, 38.93, 22.15
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.53 times
30 Thu Apr 2026 42.22 41.65 to 42.86 4.79% 1.47 times
29 Wed Apr 2026 40.29 39.70 to 40.78 -2.14% 0.95 times
28 Tue Apr 2026 41.17 41.10 to 42.08 -0.05% 0.96 times
27 Mon Apr 2026 41.19 40.55 to 41.73 0.05% 0.97 times
24 Fri Apr 2026 41.17 38.22 to 41.23 6.88% 1.2 times
23 Thu Apr 2026 38.52 38.02 to 39.20 -1.61% 0.72 times
22 Wed Apr 2026 39.15 38.85 to 39.33 -0.68% 1.02 times
21 Tue Apr 2026 39.42 38.70 to 40.20 -2.59% 1.47 times
20 Mon Apr 2026 40.47 39.75 to 40.85 -0.12% 0.47 times
17 Fri Apr 2026 40.52 40.43 to 41.29 -1% 0.77 times
16 Thu Apr 2026 40.93 40.23 to 41.66 0.29% 0.73 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top